CLINICAL STUDY TO EVALUATE THE EFFECT ON MEDICATED PASTE APPLICATION, MEDICATED DECOCTION AND TABLET IN SCIATICA

AN OPEN LABEL SINGLE ARM STUDY TO EVALUATE THE COMBINED EFFECT OF SALVANA UPANAHA SHIVAGUGGULU AND BHADRADARVADI KASHAYA IN GRIDRASI VIS A VIS SCIATICA - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035854

Enrollment

Registered

2021-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

Intervention1: Salvana Upanaha Bhadradarvadi kashaya Shivaguggulu: Salvana Upanaha for 7 days Bhadradarvadi kashaya 24ml twice a day Shivaguggulu 2tid for 15 days will be administered Control Interve

Eligibility

Inclusion criteria

Inclusion criteria: Pts presenting with lakshanas of Gridhrasi Pts presenting with signs and symptoms of sciatica

Exclusion criteria

Exclusion criteria: Pts with systemic disorders that may interfere with course of treatment pts with history of spinal fracture neoplastic condition of spine infection like TB Pregnancy and lactating women

Design outcomes

Primary

Measure	Time frame
To evaluate the combined effect of Salvana Upanaha Bhadradarvadi kashaya ShivagugguluTimepoint: 22days	—

Secondary

Measure	Time frame
NILTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDr C V Rajeshekar

SKAMCH RC

drrajhere@yahoo.co.in8867212844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026